腹膜间皮瘤：综述
Peritoneal mesothelioma: a review.
作者信息
Bridda Alessio, Padoan Ilaria, Mencarelli Roberto, Frego Mauro
机构信息
Clinica Chirurgica I, Department of Surgical and Gastroenterological Sciences, University of Padua, School of Medicine, Via Giustiniani 2, Policlinico III Piano, 35128 Padova, Italy.
出版信息
MedGenMed. 2007 May 10;9(2):32.
Abstract
Malignant peritoneal mesothelioma (MPM) is a rare aggressive tumor of the peritoneum, regarded as a universally fatal disease. It is poorly described and the knowledge of its natural history is very limited. Occupational and environmental asbestos exposure still remains a public health problem around the world. The incidence has increased in the past 2 decades. Only 20% to 33% of all mesotheliomas arise from the peritoneum itself; the pleura is the most common site of origin.
摘要
恶性腹膜间皮瘤（MPM）是一种罕见的侵袭性腹膜肿瘤，被视为一种普遍致命的疾病。对其描述甚少，对其自然史的了解也非常有限。职业和环境中的石棉暴露在全球范围内仍然是一个公共卫生问题。在过去20年中，其发病率有所上升。所有间皮瘤中只有20%至33%起源于腹膜本身；胸膜是最常见的起源部位。
相似文献
1
Peritoneal mesothelioma: a review.
MedGenMed. 2007 May 10;9(2):32.
2
[Malignant peritoneal mesothelioma tumours. Evolution, treatment, prognosis].
Rev Med Chir Soc Med Nat Iasi. 2007 Jul-Sep;111(3):673-7.
3
Treatment of Malignant Peritoneal Mesothelioma.
Klin Onkol. 2019 Fall;32(5):333-337. doi: 10.14735/amko2019333.
4
Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium.
Hematol Oncol Clin North Am. 2005 Dec;19(6):1067-87, vi. doi: 10.1016/j.hoc.2005.09.005.
5
Advances in malignant peritoneal mesothelioma.
Int J Colorectal Dis. 2015 Jan;30(1):1-10. doi: 10.1007/s00384-014-2029-1. Epub 2014 Oct 21.
6
[A case of peritoneal mesothelioma with direct invasion to gastric mucosa].
Korean J Gastroenterol. 2010 Dec;56(6):377-81. doi: 10.4166/kjg.2010.56.6.377.
7
Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.
Thorax. 2022 Dec;77(12):1260-1267. doi: 10.1136/thoraxjnl-2021-217709. Epub 2022 Feb 11.
8
['Malignant peritoneal mesothelioma': a condition difficult to diagnose].
Ned Tijdschr Geneeskd. 2012;156(15):A4269.
9
[Diffuse malignant peritoneal mesothelioma: apropos of a new case, review of the literature].
J Chir (Paris). 1989 Jun-Jul;126(6-7):388-91.
10
Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference.
Ann Oncol. 2006 Nov;17(11):1615-9. doi: 10.1093/annonc/mdl060. Epub 2006 Apr 6.
引用本文的文献
1
Retrospective analysis of mesothelioma cases in a tertiary hospital in Northern Portugal (1988-2023): An epidemiological perspective.
Porto Biomed J. 2025 Aug 5;10(4):e298. doi: 10.1097/j.pbj.0000000000000298. eCollection 2025 Sep-Oct.
2
Twice as Effective? Pressurized Intra-Thoracic Aerosol Chemotherapy: New Frontiers in Pleural Mesothelioma.
Med Sci (Basel). 2025 Jun 2;13(2):72. doi: 10.3390/medsci13020072.
3
8C7: A Fully Human Anti-PTGFRN Monoclonal Antibody-Drug Conjugate Inhibiting Tumour Growth of Mesothelioma and Paediatric Medulloblastoma Cell Lines.
J Cell Mol Med. 2025 Jun;29(12):e70665. doi: 10.1111/jcmm.70665.
4
Trends in Mesothelioma Mortality in the United States Between 1999 and 2020.
JTO Clin Res Rep. 2025 Feb 11;6(5):100804. doi: 10.1016/j.jtocrr.2025.100804. eCollection 2025 May.
5
Development and validation of a prognostic nomogram for patients with malignant peritoneal mesothelioma.
Front Oncol. 2025 Feb 28;15:1480197. doi: 10.3389/fonc.2025.1480197. eCollection 2025.
6
Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review).
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5729. Epub 2025 Feb 21.
7
Analysis of TERT mRNA Levels and Clinicopathological Features in Patients with Peritoneal Mesothelioma.
Cancers (Basel). 2025 Jan 14;17(2):252. doi: 10.3390/cancers17020252.
8
Incidence, mortality and survival of pleural mesothelioma in Zurich between 1981 and 2019, Switzerland.
J Thorac Dis. 2024 Dec 31;16(12):8240-8249. doi: 10.21037/jtd-24-766. Epub 2024 Dec 19.
9
Primary Peritoneal Mesothelioma Affecting the Greater Omentum That Mimicked an Omental Infarction: A Case Report.
Case Rep Oncol. 2024 May 30;17(1):596-601. doi: 10.1159/000538991. eCollection 2024 Jan-Dec.
10
Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments.
Cancer Res Commun. 2024 Aug 1;4(8):2133-2146. doi: 10.1158/2767-9764.CRC-23-0524.
本文引用的文献
1
An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma.
J Exp Clin Cancer Res. 2003 Dec;22(4 Suppl):41-5.
2
Comprehensive management of diffuse malignant peritoneal mesothelioma.
Eur J Surg Oncol. 2006 Aug;32(6):686-91. doi: 10.1016/j.ejso.2006.03.012. Epub 2006 Apr 18.
3
Systemic chemotherapy in the management of malignant peritoneal mesothelioma.
Eur J Surg Oncol. 2006 Aug;32(6):676-81. doi: 10.1016/j.ejso.2006.03.009. Epub 2006 Apr 17.
4
Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
Ann Surg Oncol. 2006 Mar;13(3):405-12. doi: 10.1245/ASO.2006.05.041. Epub 2006 Jan 30.
5
6
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
Cancer. 2006 Mar 1;106(5):1144-53. doi: 10.1002/cncr.21708.
7
Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Ann Surg Oncol. 2006 Feb;13(2):229-37. doi: 10.1245/ASO.2006.03.045. Epub 2006 Jan 18.
8
Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases.
Mod Pathol. 2006 Mar;19(3):373-83. doi: 10.1038/modpathol.3800543.
9
Benign multicystic peritoneal mesothelioma: cases reports in the family with diverticulosis and literature review.
Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1101-7. doi: 10.1111/j.1525-1438.2005.00198.x.
10
Update on malignant mesothelioma.
Oncology (Williston Park). 2005 Sep;19(10):1301-9; discussion 1309-10, 1313-6.
Zotero 插件